Introduction
Attention-deficit hyperactivity disorder (ADHD) is a neurobehavioral developmental disorder characterized by inattention,
Original Investigation

ADHD after fetal exposure to maternal smoking
In this study, we utilized a previously developed indicator of ADHD based on prescribed drugs in the entire population of native school children with linkage to multiple socioeconomic indicators and parental hospital care due to psychiatric illness or substance abuse . To further increase our possibilities of adjusting the analysis to genetic confounding, we also performed a separate analysis in offspring of mothers who changed smoking habits between pregnancies with the same father, to allow for a within-mother between-pregnancy approach.
Methods
This study was based on Swedish national registers held by the National Board of Health and Welfare and Statistics, Sweden. All Swedish residents are assigned a unique 10 digit ID number at birth or immigration. This ID was used to link information from different register sources.
Study population
The study population consisted of 982,856 children born at term (week 37-41) in the birth cohorts of 1987-2000, according to the Swedish Medical Birth Register (SMBR), who were recorded to be residents in Sweden on 31st December 2005 according to the Register of the Total Population. This population was followed up in 2006 at the ages of 6-19 years.
Independent variable: Smoking during pregnancy
Information on smoking during pregnancy is-as a matter of routine-collected by the midwife in three categories (nonsmoker, 1-9 cigarettes/day, and 10 cigarettes/day or more) at the first visit to the maternity health clinic, 8-12 weeks after conception. Register records from 1984 to 2005 in the SMBR were used to identify non-smoking pregnancies in women who had at least one other record of smoking during pregnancy either within a pregnancy related to the study population or to a pregnancy during 1984-1986 or 2001-2005 . Thus, four categories of smoking during pregnancy were used in this study: nonsmoking pregnancy in mothers with no record of smoking from any pregnancy, non-smoking pregnancy in mothers with a record of smoking during at least one other pregnancy, smoking 1-9 cigarettes/day during early pregnancy, and smoking 10 cigarettes/day or more during early pregnancy.
Outcome variable: ADHD medication
The Swedish Prescribed Drug Register contains data with unique patient identifiers for all drugs prescribed and dispensed to the whole population of Sweden (more than 9 million inhabitants) since July 2005 (Wettermark et al., 2007) . The purchase of at least one prescription of a drug with an Anatomical Therapeutic Chemical code of NO6BA01-NO6BA04 or NO6BA09 during the calendar year 2006, according to this register, was used to create the outcome variable of the study, ADHD medication.
There were considerable regional differences in the consumption of ADHD medication. Since these differences did not follow any obvious demographical or geographical pattern, we assumed that they mirrored varying prescription patterns in different counties rather than variations in the prevalence of ADHD. The counties were classified in four categories according to the proportion of children having purchased ADHD medication during 2006: high prescription rates (>0.8%), high average prescription rates (0.7%-0.8%), low average prescription rates (0.5%-0.6%), and low prescription rates (<0.5%).
Sociodemographic variables
Sociodemographic variables were created by linkage from several register sources. Mothers were identified in the SMBR and fathers in the Multi-Generation Register. Data on maternal age and year of birth, sex, and birth order/parity of the child were collected from the SMBR. Single parent refers to the status of the head of the household according to the Total Enumeration Income Survey of 2005. Thus, single parent may indicate either a father or a mother. Information on maternal education in 2005 was obtained through linkage to the Swedish National Education Register and classified into four categories: having 9 years or less of schooling, representing primary school only; 10-12 years, equivalent to secondary school; 13-14 years, that is, short postsecondary education; and 15+ representing a university education. Data on income from social assistance in 2005 were obtained through linkage to the Total Enumeration Income Survey of 2005. Social assistance in Sweden is a form of cash income allowance from local social authorities, after a thorough means investigation, with the purpose to guarantee the applicant a minimum standard of living.
Variables on parental psychiatric/ addictive disorder
Dichotomous variables (yes/no) of parental psychiatric and/or addictive disorders were created through linkage to the Swedish Hospital Discharge Register for the years 1973-2005 and the National Cause of Death Register (NCDR) from 1986 to 2005 with the aid of the 8th, 9th, and 10th revisions of the World Health Organization International Classification of Diseases (ICD-8, ICD-9 and ICD-10). Psychiatric disorders included psychotic and affective disorders, defined as at least one discharge or cause of death diagnosis equivalent to F20-F39 in ICD-10, and also selfinflicted injuries/suicide defined as an underlying cause of death in the NCDR or a hospital discharge with an external cause diagnosis equivalent to X60-X84 or Y10-Y34 in ICD-10. The addictive disorders included alcohol and illicit drug abuse, defined as at least one discharge or cause of death diagnosis indicating a psychiatric or somatic disorder associated with addiction to illicit narcotic drugs or alcohol, excessive alcohol consumption, and accidental overdose of an illicit narcotic drug.
Perinatal variables
Information on gestational age, low Apgar score (≤7 at 5 min), and birth weight was collected from the SMBR. Birth weight and gestational age were used to create the indicator of small for gestational age, defined as < −2 SD according to the growth chart developed by Marsal et al. (1996) .
Statistical analysis
Logistic regression was used to calculate odds ratios (ORs) with 95% CIs as estimates of effects, with consumption of ADHD medication, defined above, as the outcome variable. Analyses were made both within the whole cohort of mothers and within a subpopulation of mothers with at least one smoking and one non-smoking pregnancy (see above for definition). In this subpopulation, we selected the first pregnancy from each of the 26,292 mothers during these years and the first following pregnancy with an opposite smoking pattern (smoking vs. non-smoking).
We used four models to investigate the effects of smoking during pregnancy on ADHD medication in the 927,007 children where there was a correctly coded indicator of maternal smoking in the register. The exposure was categorized into four categories as described above, with a non-smoking pregnancy in a mother with no record of smoking as the level of comparison. In all models, we entered sex, age in 2006 in three categories (6-9, 10-15, and 16-19 years) in accordance with the age profile of medicated ADHD, year of birth as a continuous variable in accordance with the secular trend of smoking during pregnancy in Sweden, and county of residence in four categories according to level of ADHD medication. In Model 2, we added sociodemographic confounders (maternal age, birth order/parity, single parent, maternal education, and reception of social assistance in 2005). In Model 3, we added maternal and paternal psychiatric/ addictive disorder as confounders, and in the final Model 4, we added being small for gestational age and low Apgar score as possible mediators of fetal exposure to maternal smoking.
To analyze the within-subjects variation in the subpopulation of offspring of mothers with inconsistent smoking habits, we used the generalized linear model with the binomial distribution to create a conditional logistic regression where the effects were compared between pregnancies in the same mother. The model, apart from maternal ID, was adjusted for sex and birth order of each child included, age of the mother at the birth of each child included, and age of each child included at followup (= the year of ADHD medication).
In an attempt to check the validity of the indicator of smoking during pregnancy, we also analyzed the mean birth weight by maternal smoking habits in the entire study population. We also used the generalized linear model to estimate birth weight differences in offspring of smoking and non-smoking pregnancies of the same mother in an analysis adjusted for sex and birth order of each child included, age of the mother at the birth of each child included, and age of each child included at follow-up (= the year of ADHD medication). All statistical analyses were performed using SPSS version 16.0 for Windows.
This study was made with secondary data where the person ID had been replaced with an anonymous code and informed consent was thus not possible to achieve. It was performed within the framework of the governmental mission to the National Board of Health and Welfare to follow and analyze public health including prescriptions of drugs, which means that an ethical approval was not called for.
Results
In all, 6,510 children in the study population had a record of ADHD medication in the register, corresponding to 1.03% of the boys and 0.28% of the girls. The most commonly purchased drug was methylphenidate (87.8%), followed by atomoxetine (9.2%) and amphetamine (3%). In Table 1 , data on ADHD medication are cross-tabulated by smoking during pregnancy, age of child, sociodemographics, parental psychiatric morbidity, and perinatal variables. ADHD medication increased in a graded way with the pregnancy smoking habits, with the lowest rates of medication in offspring of mothers without any recorded smoking pregnancy (boys 0.78% and girls 0.20%) and highest in pregnancies with a record of smoking 10 cigarettes or more (boys 2.30% and girls 0.65%).
ADHD medication peaked in boys in the 10-to 15-year age bracket and was also more common for children in households with young mothers, single parenthood, low maternal education, need of social assistance, and parental addictive or psychiatric disorder (Table 1 ). The same factors were associated also with smoking during pregnancy ( Table 2 ).
In the majority of the study population, 71.8%, only nonsmoking during pregnancy was reported. Smoking 1-9 cigarettes/ day was reported in 12.2% of the pregnancies and 10 cigarettes/ day or more in 6.9%. A non-smoking pregnancy in mothers with a record of smoking during at least one other pregnancy was reported in 3.4% of the cases. Table 3 presents the logistic regression analyses of maternal smoking during pregnancy in the entire study population and ADHD medication. In all models, the risk of ADHD medication increased with more advanced smoking habits. The OR for ADHD medication in offspring of mothers who smoked at least 10 cigarettes/day was 2.86 in the basic model. Risks were distinctly reduced when the socioeconomic indicators were entered (Model 2) and decreased slightly when parental psychiatric and addictive disorders were also introduced (Model 3), while introducing the perinatal variables in Model 4 hardly influenced the risk figures at all. The ORs for ADHD medication in mothers who had been smoking during pregnancy were-in the fully adjusted model-1.89 for ≥10 cigarettes/day and 1.59 for 1-9 cigarettes/day. For the non-smoking mothers who had been smoking during a previous pregnancy, the corresponding OR was 1.43 compared with consistent non-smoking mothers.
The final step of the analyses was to use a within-mother between-pregnancy approach (same father in both pregnancies), thereby adjusting the analysis also to genetic and certain other types of environmental confounding. In this analysis in contrasting pregnancies for mothers with inconsistent smoking habits, the effect of smoking 10 cigarettes or more on ADHD was OR 1.26 (0.95-1.58) and 0.96 (0.73-1.13) for 1-9 cigarettes compared with non-smoking pregnancies.
The mean birth weight of the offspring varied by exposure to maternal smoking. It was lowest among smokers, 3,404 g if the mother had smoked 1-9 cigarettes/day and 3,344 g if the mother had smoked ≥10 cigarettes/day. For those who reported no smoking during any pregnancy, the mean birth weight was 3,622 g, and for non-smoking mothers who reported smoking at least once, the mean birth weight was 3,582 g. In a within-mother betweenpregnancy analysis in the subgroup of mothers with contrasting smoking habits, babies born after a pregnancy where the mother reported smoking 1-9 cigarettes/day had a birth weight that was 140 (95% CI = 132-138) g lower than that in a pregnancy where no smoking was reported and 175 (159-190) g lower when smoking at least 10 cigarettes was reported, in an analysis adjusted for age and sex of the child and parity of the mother.
Discussion
This register study in a national cohort of almost 1 million children and youth indicates that many previous reports of substantial effects of maternal smoking during pregnancy on the risk of ADHD in the offspring have been exaggerated because of genetic and socioeconomic confounding. In this study, the sex and age-adjusted OR for ADHD in offspring of mothers who smoked at least 10 cigarettes/day was 2.86, quite similar to previously reported ORs of 2.1-4.4 from case-control studies (Braun et al., 2006; Mick et al., 2002; Milberger et al., 1996 Milberger et al., , 1998 Schmitz et al., 2006) . When sociodemographic factors were entered into the analysis, the OR decreased to 2.04, demonstrating the effect of environmental factors-and possibly also to some degree genetic factors underlying the socioeconomic circumstances (e.g., parental ADHD leading to suboptimal social prerequisites). In analyses comparing data for the same mother and her two pregnancies in a within-subjects design, the OR was as low as 1.26 for ADHD medication in the offspring of a pregnancy with a smoking exposure of at least 10 cigarettes/day. This stands out as the main finding of this study. It seems likely that this further decrease primarily reflects effects of genetic confounding, but environmental confounding-including environmental expressions of the genetic confounding-may also have contributed. The importance of confounding is further underlined by the results in Model 1 in Table 3 , where the OR for ADHD medication in the offspring of non-smoking pregnancies in mothers who have at least one other pregnancy when they smoked is 1.73 compared with offspring of consistent non-smokers. Thapar et al. (2009) recently used a different design to approach the question of potential genetic confounding. In a study on children conceived with assisted reproductive technologies, they found that the magnitude of the association between smoking during pregnancy and ADHD symptoms in the offspring was larger if the child was genetically related to the mother than that if there was no genetic relation between mother and child. These findings seem to support the results from our within-mother between-pregnancy approach.
Reasonably, gene-environment interactions may account for some of the variety observed in our study. Wiebe et al. (2009) recently demonstrated that such interactions may be relevant in this field; in children with the A1+ genotype of the TaqIA polymorphism, fetal tobacco exposure meant increased risks of problem behavior.
ADHD is a difficult concept to define in a reliable way in epidemiological studies because of the subjective and contextbound nature of the impairment criteria built into existing diagnostic classifications (Polanczyk, de Lima, Horta, Biederman, & Rohde, 2007; Rowland, Lesesne, & Abramowitz, 2002) . Certainly, a number of children who meet the criteria of an ADHD diagnosis are not given medication, which challenges the validity of medication as a proxy for ADHD. In a British survey, 95% of the children who fulfilled the criteria for hyperkinetic syndrome had sought professional help during the last 12 months and medication was present in two of five of these children (Green, McGinnity, Meltzer, Ford, & Goodman, 2005) . Data from the United States demonstrate similar rates of medication in children who met DSM-IV criteria for ADHD and also reveal that medication rate may be affected by factors that are not related to the disorder itself (Froehlich et al., 2007) . For instance, poverty meant a much lower medication rate-less than one third for the poorest (first quintile) compared with other children. We believe, however, that ADHD medication may be a quite valid indicator of the more severe cases of ADHD in a Swedish context . First, national guidelines for medication of ADHD issued by the Swedish National Board of Health and Welfare clearly indicate that medication should be reserved for cases where other supportive interventions have failed. Second, the right to prescribe stimulants for ADHD is restricted to specialists with particular familiarity with treatment of this disorder. Third, psychiatric care is free and available to all in a fairly equitable manner, meaning that the low medication rates in poor children reported in the epidemiological study from the United States mentioned above may not be valid for poor children in Sweden. Contrarily, we have recently reported that social adversity predicts ADHD medication in school children .
Hypothetically, the relative genetic contribution to ADHD may be stronger for the more severe cases, and the prenatal nicotine exposure may be more strongly expressed in children with less severe behavior problems. However, this does not explain the much lower risk achieved with the within-mother between-pregnancy approach than with the logistic regression analyses of maternal smoking during pregnancy in the entire study population.
Many factors apart from the severity of the symptoms of ADHD may influence whether a specific child with ADHD is treated with medication, but few, if any, of these can be expected to vary systematically by changing smoking habits within the same family. Medication rates vary among counties probably due to different local routines and policies. This potential bias was adjusted for in the analyses.
The measure of smoking during pregnancy is based on one assessment only, performed by the midwife at 8-to 12-week postconception. We regard this measure as a proxy for the smoking pattern during the pregnancy, but it is uncertain to what extent it actually represents smoking habits during later phases of the pregnancy. The question itself, and particularly the interview situation in which it is taken up, may influence future smoking to some degree. Given presumed social desirability mechanisms, it may have been more common that smoking mothers reported non-smoking than the opposite. The lower birth weight in the pregnancies reported as smoking, 174 g lower for pregnancies with 10 cigarettes/ day or more in the within-mothers between-pregnancies substudy, however, seems to indicate that such bias, if present, was limited.
As mentioned above, the information about parental psychiatric and addictive disorders was collected from hospital care only, meaning that no outpatient psychiatric care could be adjusted for. For instance, hospital care is a poor measure for parental ADHD, which certainly would have been of interest in this study. This further demonstrates the advantage of the within-mother between-pregnancy design, where the adjustment is inherent in the model, however, not being able to take changes in parental health between the pregnancies in focus into consideration.
Several methodological issues claimed to be of importance in this research area (Linnet et al., 2003) have been considered with our approach: prospective collection of data (no recall bias), low attrition (lacking information about smoking in 5.7% of the pregnancies; see Table 2 ), use of whole national cohorts with large number of individuals (almost 1 million children) allowing for satisfactory statistical power even in analyses of mothers with different smoking habits between pregnancies, and availability of a graded smoking variable. The within-mother between-pregnancy substudy allowed us to adjust the analysis to genetic risk factors, apart from the sociodemographic, psychosocial, and perinatal variables that can be accounted for also in a cohort design.
There are several good reasons for not smoking during pregnancy, and our results should not be used as arguments for changing recommendations about this. However, the results of the within-mother between-pregnancy analyses may contribute to the discussion about how powerful strategies for preventing ADHD should be designed.
It is reasonable to believe that the prerequisites for cognitive development-and thereby also for ADHD-differ between countries due to a large variety of factors. We believe, however, that the discrepancy between the results obtained with the withinmother between-pregnancy design and the results from the logistic regression analyses involving the whole study population are generalizable to other countries even if the magnitude of this discrepancy may vary to some degree.
To conclude, smoking during pregnancy has a strong association with ADHD in the offspring in the general Swedish population, but this risk is primarily explained by genetic and socioeconomic confounding. The within-mother betweenpregnancy design is a method with a good potential for studying a large variety of questions about fetal exposures during pregnancy and psychiatric outcomes in the offspring, where genetic and environmental confounding can be anticipated.
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